{"id":"W4412756476","doi":"10.1016/j.jfma.2025.07.023","title":"Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from Taiwan","year":2025,"lang":"en","type":"article","venue":"Journal of the Formosan Medical Association","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital","funders":"Gilead UK and Ireland Corporate Contributions; Gilead Sciences","keywords":"Medicine; Tenofovir alafenamide; Tenofovir; Chronic hepatitis; Virology; Internal medicine; Gastroenterology; Hepatitis B; Human immunodeficiency virus (HIV); Virus; Antiretroviral therapy; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001950726,0.0008711544,0.001222341,0.0003496322,0.0003978183,0.0005945408,0.0004396405,0.0005908914,0.001652934],"category_scores_gemma":[0.001365683,0.0003356967,0.001338383,0.0004033764,0.0005202033,0.0003714791,0.0003587732,0.0008363987,0.0002687661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007587915,"about_ca_system_score_gemma":0.001702001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002700944,"about_ca_topic_score_gemma":0.00419472,"domain_scores_codex":[0.9993894,0.0002923431,0.00006562623,0.00009869983,0.00004331792,0.0001105153],"domain_scores_gemma":[0.9990232,0.0001641459,0.0002387842,0.000128185,0.0001403942,0.0003052506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4770303,0.04986602,0.3097227,0.001454756,0.008676019,0.001589711,0.001958044,0.001659036,0.05164941,0.0001593843,0.003150309,0.09308433],"study_design_scores_gemma":[0.2323473,0.3018923,0.447204,0.0001315362,0.004864147,0.001901105,0.0008873146,0.001829196,0.005153238,0.0001453915,0.003538345,0.0001061052],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99854,0.0002335483,0.0001125866,0.00005053033,0.000006240499,0.0005781255,0.0002808126,0.000007782938,0.0001903795],"genre_scores_gemma":[0.9964879,0.0003130151,0.0003852499,0.0002647077,0.00002904414,0.0008599765,0.001273137,0.000005766994,0.0003812965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002700944,"threshold_uncertainty_score":0.01031655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004137833328268673,"score_gpt":0.2653256416711925,"score_spread":0.2611878083429238,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}